... in its biological function and implied that targeting aberrant β1,6-branching of N-glycans on CD147 would be valuable for the development of novel therapeutic modalities against carcinoma. 2 Correspondence may be addressed to either of these authors (email [email protected] or zhinanchen...

...Elvira CRESCENZI; Giuseppe PALUMBO; Hugh J. M. BRADY The apoptosis regulator Bcl-2 has been shown to modulate cell-cycle progression, favouring a quiescent state over a proliferative state, in both normal and tumour cells. We show here that constitutive expression of Bcl-2 in human carcinoma cells...